Treatment Reduces Virus Death Risk And Daily Growth Of New Cases, Study

Treatment Reduces Virus Death Risk And Daily Growth Of New Cases, Study : An aerosol-based drug treatment could drastically reduce the number of new coronavirus patients dying from the disease or requiring intensive care, according to preliminary results released Monday by a British biotech firm.

Treatment Reduces Virus Death Risk And Daily Growth Of New Cases, Study

By Denis Lovrovic

An aerosol-based drug treatment could drastically reduce the number of new coronavirus patients dying from the disease or requiring intensive care, according to preliminary results released Monday by a British biotech firm.

interesting reading:  Disney World to reopen as coronavirus cases surge in Florida

In a randomised trial of 100 patients admitted to hospital with COVID-19, those who received an inhaled formula of the protein interferon beta were at 79 percent lower risk of developing severe disease compared to those who received a placebo. 

interesting reading:  Google Play Music Given Death Sentence By Google

They were also more than twice as likely to make a full recovery compared with the control group. 

The firm behind the treatment, known as SNG001, said the preliminary results suggested “a major breakthrough” in the pandemic.

“We are all delighted with the trial results announced today, which showed that SNG001 greatly reduced the number of hospitalised COVID-19 patients who progressed from requiring oxygen to requiring ventilation,” said Richard Marsden, CEO of Synairgen. 

The results published Monday have not yet been peer-reviewed and the sample size is relatively small. 

interesting reading:  There is a risk of urban flooding during the monsoon

But if confirmed the treatment could revolutionise the way COVID-19 is dealt with in hospitals. 

Interferon beta is a naturally occurring protein, commonly used to treat multiple sclerosis. 

It forms part of the body’s natural fight against infection and Death Risk, and the novel coronavirus suppresses its production in an attempt to evade an immune response. 

Originally published at AFP

Leave a Reply

Your email address will not be published. Required fields are marked *

Captcha loading...